CUR Curidium Medica

 

TIDMCUR TIDMAVCT 
 
RNS Number : 1656N 
Curidium Medica PLC 
11 February 2009 
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN OR INTO OR 
FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE 
RELEVANT LAWS OF SUCH JURISDICTION 
Curidium Medica plc 
("Curidium" or "the Company") 
 
 
RESULTS OF COURT MEETING AND EXTRAORDINARY GENERAL MEETING 
 
 
 
 
 
 
  *  The board of Avacta Group plc announced on 9 January 2009 the terms of a 
  recommended share offer for Curridium Medica plc by way of scheme of arrangement 
  (the "Scheme"). The share offer will be made by Avacta Group plc for the 
  cancellation of the Scheme Shares. 
 
 
 
  *  On 16 January 2009 the Company dispatched to its shareholders a circular 
  containing, inter alia, the terms of the Scheme (the "Scheme Document") and 
  notices convening the Court Meeting and the General Meeting. 
 
 
 
  *  The Directors are pleased to announce that, at the Court Meeting held on 11 
  February 2009 the resolution approving the Scheme was passed by the requisite 
  majority on a poll. 
 
 
 
  *  The voting of those members who cast votes either in person or by proxy at the 
  Court Meeting is summarised below: 
 
 
 
Court Meeting 
 
 
+----------+-------------------+------------------+------------------+ 
|          | No: of Scheme     | No: of Scheme    | % of Scheme      | 
|          | Shareholders      | Shares Voted     | Shares Voted as  | 
|          | Voting            |                  | a % of Total     | 
|          |                   |                  | Votes Received   | 
+----------+-------------------+------------------+------------------+ 
| For      |        41         |    13,046,058    |      99.99       | 
+----------+-------------------+------------------+------------------+ 
| Against  |        1          |      1,333       |      0.01        | 
+----------+-------------------+------------------+------------------+ 
 
 
  *  At the General Meeting also held on 11 February 2009 the Company's Shareholders 
  passed the special resolution to approve the Scheme and the associated reduction 
  of capital by a show of hands. 
 
 
 
  *  In addition to the special resolution to approve the Scheme, special resolutions 
  to cancel the Deferred Shares and to amend the Company's articles of association 
  were put to the General Meeting held on 11 February 2009. On 11 February 2009 
  the Company's Shareholders passed the special resolutions to cancel the Deferred 
  Shares and to amend the Company's articles of association by a show of hands. 
 
 
 
  *  Completion of the Scheme remains subject to the sanction of the Court. The Court 
  hearing to sanction the Scheme is expected to take place on 2 March 2009. It is 
  expected that the Scheme will become effective on 3 March 2009. 
 
 
 
  *  On the basis that the Scheme becomes effective on 3 March 2009, Cancellation of 
  the listing and dealing of Ordinary Shares in Curidium and the Issue of the New 
  Avacta Shares will occur at 8am on 4 March 2009. 
 
 
 
Capitalised terms used in this announcement have the same meanings in the 
circular and Scheme Document. 
 
 
Enquiries 
Curidium 
Dr. Barry Porter, Chairman 
Rob Smith, Chief Financial Officer 
Tel: 020 7554 5100 
Avacta 
Dr Alastair Smith, Chief Executive Officer 
Tim Sykes, Chief Financial Officer 
Tel: 0870 835 4367 
FinnCap (financial adviser to Curidium) 
Charlie Cunningham 
Tel: 020 7600 1658 
Novum Securities Limited (financial adviser to Avacta) 
Henry Turcan 
Tel: 020 7562 4700 
Haggie Financial (PR to Avacta) 
Nicholas Nelson 
Tel: 020 7417 8989 
FinnCap, which is authorised and regulated in the UK by the Financial Services 
Authority, is acting as financial adviser and broker to Curidium in connection 
with the Recommended Offer and no-one else and will not be responsible to anyone 
other than Curidium for providing the protections afforded to clients of FinnCap 
nor for providing advice in relation to the Recommended Offer nor any other 
matter referred to in this announcement. 
 
 
Novum Securities Limited, which is authorised and regulated in the UK by the 
Financial Services Authority, is acting as financial adviser to Avacta in 
connection with the Recommended Offer and no-one else and will not be 
responsible to anyone other than Avacta for providing the protections afforded 
to clients of Novum Securities nor for providing advice in relation to the 
Recommended Offer nor any other matter referred to in this announcement. 
 
 
 
 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 STRGUUAUPUPBGCG 
 

Curidium Medica (LSE:CUR)
Historical Stock Chart
From May 2024 to Jun 2024

Curidium Medica (LSE:CUR)
Historical Stock Chart
From Jun 2023 to Jun 2024